1999

• Dec.Automated the manufacturing facility for compound liquid formulations.

• Aug.Joint technology partnership with 'ICN' in the United States for the release of Libra, Dalmadorm, and Mestinone.

• Jul.Successful resolution of patent dispute with Landsise.

• MayJoint technology partnership with 'BIOTEST' in Germany (Megarotex, Pentaglobin).

1998

• Dec.Registration of patent No, 183183 (Traditional medicine liquid containing cold medicine ingredients)

1997

• Mar.Award the president's commendation on commerce day.

• Jan.Registration of patent No. 111249 (Landsise)

1996

• Jul.Completion of advanced logistics building.

• Jan.Release of Biafine, a dermatological treatment product; through a technology partnership with 'Medix' in France.

• Jan.Commencement of exports to Singapore and Vietnam.

1995

• Oct.Completion of the construction of the central research institute building.

• Mar.Selected as one of top 100 promising small and medium sized enterprises in Gyeonggi province.

• Mar.Completion of automated sewage treatment facility.

1994

• Nov.Designation as an exemption from military service company.

• Apr.Joining the Korea Drug Development Research Association.

1993

• Dec.Awarded the excellence in workplace by Gyeonggi province.

• Nov.Approval for the establishment of the central research institute.

• Apr.Expansion of solid dosage form manufacturing facility.

• Mar.Addition of KGMP-approved facility for external liquid products.

• Jan.Introduction of automated manufacturing facility for liquid products.

1991

• Aug.Open on line connection between Seoul headquarters and Icheon factory, and introduction of computerizing system.

• Jul.Obtained food processing and manufacturing license.

• Apr.Designation as a KGMP-approved facility for comprehensive pharmaceutical manufacturing and management standards (No 64).

• Apr.Commencement of exports to Pakistan.

1990

• Jan.Completion of GMP facility construction and expansion at the factory.

• Jan.Promotion of claim zero campaign.